Related Experiment Video
Updated: May 23, 2026
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
Sirtuin modulators: mechanisms and potential clinical implications.
S Sanchez-Fidalgo1, I Villegas, M Sanchez-Hidalgo
1Department of Pharmacology, School of Pharmacy, University of Seville, Spain. fidalgo@us.es
Current Medicinal Chemistry
|March 30, 2012
Summary
Sirtuins (SIRTs) are key to longevity and aging. These enzymes may protect against age-related diseases, offering potential therapeutic targets for conditions like cardiovascular disease and neurodegeneration.
Area of Science:
- Cellular Biology
- Molecular Biology
- Gerontology
Background:
- Caloric restriction and Silent Information Regulator 2 (SIR2) gene activity are linked to reduced aging damage.
- Sirtuins (SIRTs), evolutionarily conserved proteins, are crucial for health and survival.
- Seven mammalian SIRT classes exist, with many functions still under investigation, but they show potential in combating age-related diseases.
Purpose of the Study:
- To review the protective roles of sirtuins against aging-associated diseases.
- To summarize novel mechanisms underlying sirtuin activity.
- To evaluate the potential clinical applications of sirtuin modulation.
Main Methods:
- Review of existing literature on sirtuins and aging.
- Analysis of studies involving molecule activators/inhibitors and genetically engineered animals.
- Examination of sirtuin's enzymatic activity involving NAD(+) and ADP-ribosyltransferase functions.
Main Results:
- Sirtuins are NAD(+)-dependent protein deacetylases and ADP-ribosyltransferases.
- SIRT enzymatic activity is crucial for metabolic homeostasis, impacting tumorigenesis, inflammation, cardiovascular health, and neurodegeneration.
- Sirtuins are implicated as key mediators of longevity across various model organisms.
Conclusions:
- Sirtuins play a significant role in mediating the aging process.
- Modulating sirtuin activity presents promising therapeutic avenues for age-related diseases.
- Further research into sirtuins could lead to novel treatments for conditions like cancer, cardiovascular diseases, and neurodegenerative disorders.
Related Concept Videos
02:04Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:19Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: